Domestic market

Uni-Medica reagents and instruments have carried out related projects in many hospitals in China, including Gynecological projects, Cytokine detection, CD161 detection, etc.

The First Affiliated Hospital of Zhengzhou University

Chinese Pla General Hospital

Children's Hospital of Shanghai

The Second People's Hospital of Shenzhen

The Third People's Hospital of Shenzhen

Maternal and Child Health Care Hospital of Yunnan

International market

For Novel Coronavirus Nucleic Acid testing requirements, Uni-Medica provides total solution of Novel Coronavirus 2019-nCoV Nucleic Acid Detection, including Sampling, Nucleic Acid Extraction and PCR Detection. In the field of Nucleic Acid Extraction, Uni-Medica provides Automatic Nucleic Acid Extraction instrument, Automatic Nucleic Acid Workstation with functions of loading samples from the original tube and mixing PCR liquid, and supporting high-performance nucleic acid extraction reagents. For PCR detection, Uni-Medica will provide Novel Coronavirus Nucleic Acid Detection and differential diagnosis reagent with high sensitivity and fluorescence quantitative PCR instrument.

As the preferred supplier of nucleic acid testing reagents and instruments for COVID-19 worldwide, Uni-Medica's products have obtained CE certificates , and obtained registration certificates in the Philippines, India, Peru, The United Arab Emirates, Thailand, Bangladesh and other countries. These kits have been exported to many countries around the world, contributing to the prevention and control of global pathogenic microbial infectious diseases.

Message